P06526
Gene name |
DNTT (TDT) |
Protein name |
DNA nucleotidylexotransferase |
Names |
Terminal addition enzyme, Terminal deoxynucleotidyltransferase, TDT, Terminal transferase |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:281120 |
EC number |
2.7.7.31: Nucleotidyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P06526
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P06526-F1 | Predicted | AlphaFoldDB |
50 variants for P06526
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs446610835 | 3 | P>Q | No | EVA | |
| rs478044320 | 3 | P>T | No | EVA | |
| rs467029788 | 5 | C>G | No | EVA | |
| rs467029788 | 5 | C>S | No | EVA | |
| rs480735466 | 6 | T>P | No | EVA | |
| rs469358855 | 19 | V>G | No | EVA | |
| rs468755473 | 21 | A>S | No | EVA | |
| rs451975219 | 31 | K>M | No | EVA | |
| rs465625653 | 33 | Q>H | No | EVA | |
| rs472883190 | 44 | M>R | No | EVA | |
| rs441647395 | 45 | G>V | No | EVA | |
| rs455310588 | 47 | T>A | No | EVA | |
| rs475434006 | 49 | R>S | No | EVA | |
| rs444039705 | 51 | F>L | No | EVA | |
| rs457996948 | 53 | M>T | No | EVA | |
| rs478164613 | 54 | E>D | No | EVA | |
| rs440158982 | 55 | L>R | No | EVA | |
| rs460312184 | 56 | A>T | No | EVA | |
| rs480446780 | 59 | K>* | No | EVA | |
| rs449390772 | 62 | R>M | No | EVA | |
| rs469518650 | 62 | R>S | No | EVA | |
| rs483018875 | 68 | S>I | No | EVA | |
| rs470999409 | 106 | W>S | No | EVA | |
| rs439866908 | 122 | K>I | No | EVA | |
| rs433109516 | 166 | H>P | No | EVA | |
| rs433109516 | 166 | H>R | No | EVA | |
| rs1115401960 | 208 | M>V | No | EVA | |
| rs449314549 | 241 | L>* | No | EVA | |
| rs472119394 | 253 | T>S | No | EVA | |
| rs1116878977 | 313 | V>M | No | EVA | |
| rs461518610 | 372 | G>R | No | EVA | |
| rs448952518 | 376 | Y>* | No | EVA | |
| rs481680703 | 376 | Y>D | No | EVA | |
| rs462690992 | 380 | V>G | No | EVA | |
| rs482601998 | 382 | S>P | No | EVA | |
| rs524234164 | 399 | H>N | No | EVA | |
| rs444879498 | 403 | C>F | No | EVA | |
| rs464948901 | 404 | F>L | No | EVA | |
| rs433835474 | 410 | H>Q | No | EVA | |
| rs467544491 | 411 | H>L | No | EVA | |
| rs447501371 | 411 | H>N | No | EVA | |
| rs456464162 | 412 | Q>* | No | EVA | |
| rs136117843 | 419 | S>A | No | EVA | |
| rs432328765 | 434 | L>M | No | EVA | |
| rs432756536 | 477 | Y>D | No | EVA | |
| rs445121454 | 483 | V>E | No | EVA | |
| rs445121454 | 483 | V>G | No | EVA | |
| rs465259804 | 493 | I>S | No | EVA | |
| rs478832692 | 506 | E>K | No | EVA | |
| rs467419336 | 509 | A>S | No | EVA |
No associated diseases with P06526
14 regional properties for P06526
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | C2 domain | 1071 - 1194 | IPR000008 |
| domain | Phosphatidylinositol-specific phospholipase C, X domain | 320 - 465 | IPR000909 |
| domain | SH2 domain | 548 - 657 | IPR000980-1 |
| domain | SH2 domain | 666 - 756 | IPR000980-2 |
| domain | SH3 domain | 791 - 851 | IPR001452 |
| domain | Phospholipase C, phosphatidylinositol-specific, Y domain | 953 - 1070 | IPR001711 |
| domain | Pleckstrin homology domain | 27 - 144 | IPR001849-1 |
| domain | Pleckstrin homology domain | 489 - 680 | IPR001849-2 |
| domain | Pleckstrin homology domain | 804 - 933 | IPR001849-3 |
| domain | EF-hand domain | 152 - 187 | IPR002048 |
| binding_site | EF-Hand 1, calcium-binding site | 165 - 177 | IPR018247 |
| domain | PLC-gamma, C-terminal SH2 domain | 663 - 765 | IPR035023 |
| domain | PLC-gamma, N-terminal SH2 domain | 545 - 649 | IPR035024 |
| domain | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, SH3 domain | 791 - 850 | IPR035724 |
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.7.31 | Nucleotidyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| DNA nucleotidylexotransferase activity | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). |
| DNA-directed DNA polymerase activity | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a DNA template and a 3'hydroxyl group. |
| metal ion binding | Binding to a metal ion. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| DNA metabolic process | Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides. |
| DNA modification | The covalent alteration of one or more nucleotide sites in DNA, resulting in a change in its properties. |
| double-strand break repair via nonhomologous end joining | The repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to the modification of broken DNA ends. This term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-NHEJ and A-NHEJ). These in turn may further branch into sub-pathways, but evidence is still unclear. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDPLCTASSG | PRKKRPRQVG | ASMASPPHDI | KFQNLVLFIL | EKKMGTTRRN | FLMELARRKG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| FRVENELSDS | VTHIVAENNS | GSEVLEWLQV | QNIRASSQLE | LLDVSWLIES | MGAGKPVEIT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| GKHQLVVRTD | YSATPNPGFQ | KTPPLAVKKI | SQYACQRKTT | LNNYNHIFTD | AFEILAENSE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| FKENEVSYVT | FMRAASVLKS | LPFTIISMKD | TEGIPCLGDK | VKCIIEEIIE | DGESSEVKAV |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LNDERYQSFK | LFTSVFGVGL | KTSEKWFRMG | FRSLSKIMSD | KTLKFTKMQK | AGFLYYEDLV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| SCVTRAEAEA | VGVLVKEAVW | AFLPDAFVTM | TGGFRRGKKI | GHDVDFLITS | PGSAEDEEQL |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LPKVINLWEK | KGLLLYYDLV | ESTFEKFKLP | SRQVDTLDHF | QKCFLILKLH | HQRVDSSKSN |
| 430 | 440 | 450 | 460 | 470 | 480 |
| QQEGKTWKAI | RVDLVMCPYE | NRAFALLGWT | GSRQFERDIR | RYATHERKMM | LDNHALYDKT |
| 490 | 500 | ||||
| KRVFLKAESE | EEIFAHLGLD | YIEPWERNA |